Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$3.40B
+30.8% from 2023
Prescriptions
256K
$13,301.42 per claim
Patients
35K
12,459 prescribers
Total spending, 2024
$3.40B
$96,156.56 per patient
Medicare prescription drug plans paid $3.40B for Xtandi in 2024, for 255,605 prescriptions and refills to 35,359 patients (up 30.8% from 2023). The average cost per claim was $13,301.42.
California had the highest Medicare cost for Xtandi in 2024: $353.8M for 27,174 claims, followed by Florida ($278.2M).
Sukumar Ethirajan, hematology in Overland Park, KS, had the highest Medicare cost for Xtandi in 2024: 1,540 claims costing $21.5M.
Xtandi is made by Astellas Pharma Inc. (4503.T), listed in the Medicare spending data as Astellas Pharma.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Sukumar Ethirajan Overland Park, KS | Hematology | 1,540 | 229 | $21.5M |
| Ryan J Malone Jeffersonville, IN | Urology | 777 | 107 | $10.5M |
| Geoffrey J Bisignani |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 10,877 | 189,079 | 27,801 | $2.44B |
| 2023 | 11,194 | 191,565 | 28,632 | $2.60B |
| 2024 | 12,459 | 255,605 | 35,359 | $3.40B |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Urology |
| 669 |
| 71 |
| $8.9M |
| John M Rutkowski Sanborn, NY | Urology | 633 | 86 | $8.0M |
| Luke T Nordquist Omaha, NE | Medical Oncology | 540 | 82 | $7.3M |
| Stewart T Landau American Fork, UT | Urology | 486 | 72 | $6.7M |
| Zachary D Reardon Mobile, AL | Urology | 506 | 63 | $6.7M |
| Peter A Zeman Wilmington, NC | Urology | 482 | 57 | $6.5M |
| Aaron D Berger Chicago Ridge, IL | Urology | 481 | 76 | $6.4M |
| Timothy J Leroy Knoxville, TN | Urology | 427 | 58 | $6.0M |
| Benjamin H Lowentritt Baltimore, MD | Urology | 379 | 70 | $5.5M |
| Walter Rayford Memphis, TN | Urology | 392 | 72 | $5.4M |
| William B Townsend Charlotte, NC | Urology | 376 | 49 | $5.2M |
| Jim Hsiang Corpus Christi, TX | Radiation Oncology | 352 | 45 | $4.9M |
| Mark D Greenberger Memphis, TN | Urology | 358 | 48 | $4.9M |
| Daniel C Danila New York, NY | Medical Oncology | 348 | 57 | $4.8M |
| Brian R Evans Florence, SC | Urology | 344 | 45 | $4.7M |
| Mark J Saslawsky Memphis, TN | Urology | 340 | 34 | $4.6M |
| Mark G Delworth Jr. Blue Ash, OH | Urology | 342 | 36 | $4.5M |
| Susan M Sargent Rochester, NY | Nurse Practitioner | 364 | 50 | $4.5M |
| Joelle P Hamilton Homewood, AL | Medical Oncology | 338 | 57 | $4.4M |
| David S Morris Hendersonville, TN | Urology | 322 | 59 | $4.3M |
| Pratik S Desai Woodbridge, VA | Urology | 294 | 39 | $4.1M |
| Scott B Sellinger Tallahassee, FL | Urology | 284 | 31 | $3.9M |
| David Degrassi Huntley, IL | Nurse Practitioner | 323 | 57 | $3.6M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Astellas Pharma 4503.T | 255,669 | $3.40B |